Drug repurposing identifies novel Wee1 kinase inhibitors for triple negative breast cancer therapeutics.
- DOI
- 10.1016/j.ejmech.2025.118340
- Published
- 2025-11-06
- Container
- Eur J Med Chem
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2025.118340,
title = {Drug repurposing identifies novel Wee1 kinase inhibitors for triple negative breast cancer therapeutics.},
author = {Pillai U J and Singh P and Maan M and Nidagodu Jayakumar M and Donakonda S and Iype E and Dutta M.},
year = {2026},
journal = {Eur J Med Chem},
doi = {10.1016/j.ejmech.2025.118340},
url = {https://doi.org/10.1016/j.ejmech.2025.118340}
}RIS
TY - JOUR TI - Drug repurposing identifies novel Wee1 kinase inhibitors for triple negative breast cancer therapeutics. AU - Pillai U J AU - Singh P AU - Maan M AU - Nidagodu Jayakumar M AU - Donakonda S AU - Iype E AU - Dutta M. PY - 2026 JO - Eur J Med Chem DO - 10.1016/j.ejmech.2025.118340 UR - https://doi.org/10.1016/j.ejmech.2025.118340 ER -
APA
J, P. U., P, S., M, M., M, N. J., S, D., E, I., & M., D. (2026). Drug repurposing identifies novel Wee1 kinase inhibitors for triple negative breast cancer therapeutics.. Eur J Med Chem. https://doi.org/10.1016/j.ejmech.2025.118340
Source records
- europe-pmc · retrieved 2026-09-26T05:44:52.459Z